Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL
J N Graff, G Baciarello, A J Armstrong, C S Higano, P Iversen, T W Flaig, D Forer, T Parli, D Phung, B Tombal, T M Beer, C N Sternberg
98Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL'. Together they form a unique fingerprint.